ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 072,42
0,29%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) Actualités

RVMD Revolution Medicines Inc

40,90
1,71 (4,36%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Revolution Medicines Inc RVMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,71 4,36% 40,90 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
40,00 39,10 40,21 40,20 39,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:05GLOBERevolution Medicines to Report Financial Results for First..
09/4/202421:34GLOBERevolution Medicines Announces Publication on the Discovery..
08/4/202417:36GLOBERevolution Medicines Announces Publications on the Discovery..
04/4/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28/3/202421:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26/2/202422:04EDGAR2Form 8-K - Current report
20/2/202422:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09/2/202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202420:15EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
20/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202300:22EDGAR2Form 144 - Report of proposed sale of securities
14/12/202323:48EDGAR2Form 144 - Report of proposed sale of securities
21/11/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:14EDGAR2Form 144 - Report of proposed sale of securities
16/11/202320:58EDGAR2Form CERT - Certification by an exchange approving..
15/11/202322:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
15/11/202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202315:20EDGAR2Form 8-K - Current report
09/11/202315:10GLOBERevolution Medicines Completes Acquisition of EQRx
08/11/202317:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
06/11/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
06/11/202322:05EDGAR2Form 8-K - Current report
01/11/202312:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202312:11EDGAR2Form 425 - Prospectuses and communications, business..
01/11/202312:08EDGAR2Form 8-K - Current report
01/11/202312:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
31/10/202321:15GLOBERevolution Medicines to Report Financial Results for Third..
24/10/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:13EDGAR2Form 425 - Prospectuses and communications, business..
23/10/202312:11EDGAR2Form 8-K - Current report
22/10/202308:30GLOBERevolution Medicines Presents Promising Clinical Activity..
13/10/202317:54EDGAR2Form 8-K - Current report
13/10/202317:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
04/10/202322:05GLOBERevolution Medicines to Present New Clinical Data at Major..
02/10/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..

Dernières Valeurs Consultées

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés